Considering the cardiometabolic outcomes under study, we identified consistent mendelian randomisation and colocalisation evidence for circulating TRAIL increasing coronary artery disease risk; IL1RA and MIF decreasing CRP levels; and IL1RA increasing circulating low density lipoprotein cholesterol, total cholesterol, and glucose concentrations. This evidence concerns the gene TNFSF10 and coronary artery disorder.